pcI-ts,ind+-(NSP8) Citations (2)

Originally described in: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase.
Dangerfield TL, Huang NZ, Johnson KA iScience. 2020 Nov 28:101849. doi: 10.1016/j.isci.2020.101849. PubMed Journal

---

Articles Citing pcI-ts,ind+-(NSP8)

Articles
Expression and purification of tag-free SARS-CoV-2 RNA-dependent RNA polymerase in Escherichia coli. Dangerfield TL, Huang NZ, Johnson KA. STAR Protoc. 2021 Mar 19;2(1):100357. doi: 10.1016/j.xpro.2021.100357. Epub 2021 Feb 4. PubMed
Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication. Bravo JPK, Dangerfield TL, Taylor DW, Johnson KA. Mol Cell. 2021 Apr 1;81(7):1548-1552.e4. doi: 10.1016/j.molcel.2021.01.035. Epub 2021 Jan 28. PubMed

If you have published an article using this material, please email us at to have your article added to this page.